Pepdox
Studies
Peptides
Calculator
Oral Semaglutide Therapy Reduces Cardiovascular Events in Patients with Type 2 Diabetes: Deciphering the Soul of the Study. | Pepdox
Home
/
Search
/
PMID 40429331
Oral Semaglutide Therapy Reduces Cardiovascular Events in Patients with Type 2 Diabetes: Deciphering the Soul of the Study.
Journal of clinical medicine
2025
PMID: 40429331
View on PubMed
DOI: 10.3390/jcm14103335
Semaglutide
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-IRAs) have become pivotal in the management of type 2 diabetes mellitus (T2DM) [...].
Authors
Jialal, Ishwarlal; Olatunbosun, Samuel T